NIRF induces G1 arrest and associates with Cdk2

Biochemical and Biophysical Research Communications

Volumn 319, Issue 2, 2004, Pages 464-468

  Li, Yuanyuan ^a   Mori, Tsutomu ^a   Hata, Hiroaki ^a   Homma, Yoshimi ^a   Kochi, Hideo ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cdk2; Cell cycle; Phosphorylation; RING finger protein

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN E; NUCLEAR PROTEIN;

ARTICLE; CELL CYCLE G1 PHASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

CDC2-CDC28 KINASES; CELL LINE; CYCLIN-DEPENDENT KINASE 2; FLOW CYTOMETRY; G1 PHASE; HUMANS; PHOSPHORYLATION; UBIQUITIN-PROTEIN LIGASES;

EID: 2642516265     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.04.190     Document Type: Article

References (27)

1. Herwig S., Strauss M. The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur. J. Biochem. 246:1997;581-601
2. Nevins J.R., Leone G., DeGregori J., Jakoi L. Role of the Rb/E2F pathway in cell growth control. J. Cell. Physiol. 173:1997;233-236
3. Resnitzky D., Reed S.I. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell. Biol. 15:1995;3463-3469
4. Ohtsubo M., Theodoras A.M., Schumacher J., Roberts J.M., Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15:1995;2612-2624
5. Lukas J., Herzinger T., Hansen K., Moroni M.C., Resnitzky D., Helin K., Reed S.I., Bartek J. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11:1997;1479-1492
6. Dimri G.P., Nakanishi M., Desprez P.Y., Smith J.R., Campisi J. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol. Cell. Biol. 16:1996;2987-2997
7. Santoni-Rugiu E., Falck J., Mailand N., Bartek J., Lukas J. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway. Mol. Cell. Biol. 20:2000;3497-3509
8. Berns K., Hijmans E.M., Bernards R. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E-CDK2 kinase activity. Oncogene. 15:1997;1347-1356
9. Mori T., Li Y., Hata H., Ono K., Kochi H. NIRF, a novel RING finger protein, is involved in cell-cycle regulation. Biochem. Biophys. Res. Commun. 296:2002;530-536
10. Fujimori A., Matsuda Y., Takemoto Y., Hashimoto Y., Kubo E., Araki R., Fukumura R., Mita K., Tatsumi K., Muto M. Cloning and mapping of Np95 gene which encodes a novel nuclear protein associated with cell proliferation. Mamm. Genome. 9:1998;1032-1035
11. Hopfner R., Mousli M., Jeltsch J.M., Voulgaris A., Lutz Y., Marin C., Bellocq J.P., Oudet P., Bronner C. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. Cancer Res. 60:2000;121-128
12. Bonapace I.M., Latella L., Papait R., Nicassio F., Sacco A., Muto M., Crescenzi M., Di Fiore P.P. Np95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry. J. Cell Biol. 157:2002;909-914
13. Muto M., Kanari Y., Kubo E., Takabe T., Kurihara T., Fujimori A., Tatsumi K. Targeted disruption of Np95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks. J. Biol. Chem. 277:2002;34549-34555
14. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 227:1970;680-685
15. Hsu J.Y., Reimann J.D., Sorensen C.S., Lukas J., Jackson P.K. E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC (Cdh1). Nat. Cell Biol. 4:2002;358-366
16. Gu Y., Rosenblatt J., Morgan D.O. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11:1992;3995-4005
17. Sheaff R.J., Groudine M., Gordon M., Roberts J.M., Clurman B.E. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11:1997;1464-1478
18. Bartek J., Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 490:2001;117-122
19. Hoffmann I., Draetta G., Karsenti E. Activation of the phosphatase activity of human cdc25A by a Cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J. 13:1994;4302-4310
20. Aprelikova O., Xiong Y., Liu E.T. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J. Biol. Chem. 270:1995;18195-18197
21. Mori T., Li Y., Hata H., Kochi H. NIRF is a ubiquitin ligase that is capable of ubiquitinating PCNP, a PEST-containing nuclear protein. FEBS Lett. 557:2004;209-214
22. Adams M.R., Sears R., Nuckolls F., Leone G., Nevins J.R. Complex transcriptional regulatory mechanisms control expression of the E2F3 locus. Mol. Cell. Biol. 20:2000;3633-3639
23. Lasorella A., Noseda M., Beyna M., Yokota Y., Iavarone A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature. 407:2000;592-598
24. Stad R., Little N.A., Xirodimas D.P., Frenk R., van der Eb A.J., Lane D.P., Saville M.K., Jochemsen A.G. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep. 2:2001;1029-1034
25. Pan Y., Chen J. MDM2 promotes ubiquitination and degradation of MDMX. Mol. Cell. Biol. 23:2003;5113-5121
26. Badciong J.C., Haas A.L. MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination. J. Biol. Chem. 277:2001;49668-49675
27. Knuutila S., Aalto Y., Autio K., Bjorkqvist A.M., El-Rifai W., Hemmer S., Huhta T., Kettunen E., Kiuru-Kuhlefelt S., Larramendy M.L., Lushnikova T., Monni O., Pere H., Tapper J., Tarkkanen M., Varis A., Wasenius V.M., Wolf M., Zhu Y. DNA copy number losses in human neoplasms. Am. J. Pathol. 155:1999;683-694